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Background/aim: We aimed to elucidate the causes of the increased melanisation in basal cell carcinoma (BCC) and seborrheic keratosis
(SK), and the role of melanocytes in this process.
Materials and methods: This study was a retrospective-cohort study conducted in the pathology department of a university hospital
between January 2019 and October 2020. Forty-nine SK and 30 pigmented BCC were included in our study. SRY-box transcription
factor 10 (SOX10), CD68, and Masson–Fontana staining was used for analysis in all samples. A representative section of each specimen
was photographed under ×400 magnification to facilitate the assessments of the morphology of the melanocytes and their following
morphometric parameters: density, nuclear diameter, and distribution. The density of pigmented keratinocytes in the lesional epidermis
was scored. The nuclear diameters of melanocytes located in the nonlesional epidermis, the density of the melanophages, and the
presence or absence of ulceration and solar elastosis were also recorded.
Results: The morphometric findings confirmed a statistically significant increase in melanocyte density in the BCC group compared
with that in the SK group (p < 0.001). Moreover, the nuclear minor diameters in the melanocytes of the BCC sections were significantly
higher than those in the SK specimens (p < 0.001). The epidermal melanocytes were distributed diffusely in almost all BCC specimens
(96.7%), whereas they were mainly limited to the basal layer in the majority of the SK sections (59.2%).
The number of epidermal melanised keratinocytes with a score of 3 was significantly higher in the SK group (n = 31; 63.2%) than in the
BCC group (n = 6; 20%) (p = 0.001), and they were the main cells representing the pigmented appearance of the tumours. No significant
difference was found between both tumour groups in terms of their melanophage density scores (p = 0.206).
Conclusion: This study is the first step towards an objective quantification of the melanocytes in pigmented epithelial tumours and may
provide a morphological background for future studies on these skin lesions.
Key words: Pigmentation, melanisation, basal cell carcinoma, seborrheic keratosis, SOX10

1. Introduction
Melanocytes, which are melanin-producing cells that
originate from the neural crest, are located in the
basal cell layer of the epidermis. These cells produce
melanin from l-3,4-dihydroxyphenylalanine (l-DOPA)
after synthesising the latter from tyrosine. Aside from
protecting the skin from ultraviolet radiation through
their production of melanin, melanocytes also play a role
in the immune system [1]. However, melanin synthesis
has also been found to occur in basal cell carcinoma
(BCC) and seborrheic keratosis (SK), two common
pigmented tumours of the skin epithelium. Despite that
increased melanin production is common in benign and

malignant epithelial skin tumours, only a limited number
of studies have focused on the exact cause of the increased
melanisation and the role played by melanocytes in the
pathogenesis of these neoplasms. It has been reported
that endothelin-1, a keratinocyte-derived cytokine with a
stimulatory effect on melanocytes, may play a role in the
melanisation of SK [2].
Melanin pigments, which are synthesised and
deposited in melanocyte organelles called melanosomes,
are generally transferred to an average of 36 keratinocytes
through the latter’s phagocytosis of the melanosomeloaded dendritic ends of the melanocytes. Proteaseactivated receptor 2 (PAR-2), a key receptor expressed
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on keratinocytes, is involved in melanosome transfer [3].
Other important regulators of this process are kinesin
and actin-related myosin V, the latter of which protects
the peripheral melanosomes and prepares them for
transfer to the surrounding keratinocytes [4]. It is well
known that any inflammatory process involving melanin
transfer in the basal layer of the epidermis, specific enzyme
defects, and the destruction of melanocytes are causes
of hypopigmentation [1]. However, the pathogenesis of
hyperpigmentation is not well understood.
Currently, there are many markers in use for the
histopathological identification of melanocytes. SRY-box
transcription factor 10 (SOX10), a transcription factor
that plays a role in the development of melanocytes, is
considered a suitable nuclear marker for the morphometric
analysis of these cells because of its high sensitivity and
specificity [5–7]. In this context, we surmised that it would
be easy to identify and evaluate the melanocytic cells in
BCC and SK using this marker.
In this study, we aimed to elucidate the causes of
the increased melanisation in BCC and SK, and the
role of melanocytes in this process, by investigating the
morphological and morphometric differences in SOX10identified melanocytes in these two types of skin tumours.
We also aimed to assess the contribution of melanophages
in other causes of increased melanisation by using the
CD68 antibody.
2. Materials and methods
2.1. Patients
This study was a retrospective-cohort study conducted in
the pathology department of a university hospital between
January 2019 and October 2020. Histopathological slides
of skin tumour tissue from patients who were previously
diagnosed with BCC or SK were retrieved from the
pathology files and reexamined. Patients whose diagnoses
were confirmed by at least two pathologists (A.K.; M.G.)
experienced in dermatopathology were included in the
study, and their clinical and demographic characteristics
were recorded along with the histopathological subtypes
of the tumours.
2.2. Inclusion and exclusion criteria
The inclusion criteria were as follows: a precise
histopathological diagnosis of BCC or SK; availability
of sufficient clinical information; sufficient pathology
specimens for analysis; pathologically confirmed clear
surgical margins; and the presence of pigmentation in
at least 1% of the whole section. Collision tumours were
excluded.
2.3. Histopathological and immunohistochemical
analysis
Representative paraffin-embedded blocks of tissue
with the most intense pigmentation in the epidermis
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were sectioned and the tissue slices were processed for
immunohistochemical examination using the standard
avidin-biotin-peroxidase complex method. The antibody
used was raised against SOX10 (EP268, BioSB, Santa
Barbara, CA, USA), and a red chromogen was applied for
antigen localisation. Proper positive and negative controls
were run in parallel. Cells with a nuclear staining pattern
indicated positive immunostaining for SOX10, whereas
those with no staining or a cytoplasmic staining pattern
indicated negative immunostaining. A representative
section of each specimen was photographed under
×400 magnification to facilitate the assessments of the
morphology of the melanocytes and their following
morphometric parameters: density, nuclear diameter, and
distribution (Figure 1–4). For the melanocyte density, the
hot spot field of SOX10 positive melanocytes in each tissue
section was determined and it was counted in high power
of magnification (×400). (Figure 2). The nuclear diameter
was obtained by measuring the short axis of the three
largest melanocytes within a 500 µm (×400) segment of
the section and then recording the mode (Figure 3). The
tendency of the SOX10-positive melanocytes to show
diffuse or epidermal basal distribution was noted (Figure
4). The nuclear diameters of melanocytes located in the
nonlesional epidermis, the density of the melanophages,
and the presence or absence of ulceration and solar
elastosis were also recorded. The density of melanophages
in the dermis adjacent to the tumour was graded using
CD68 (KP1, MS-397-P; Thermo Scientific; Fremont,
CA, USA) and Masson–Fontana staining (0–5:0, 6–10:1,
11–15:2, >15:3) (Figure 5). To calculate the melanophage
density, on each slide, a representative area was chosen.
The number of melanophages in one high-power (×40
objective) field was counted. The possibility of siderophage
formation was excluded using Prussian blue staining.
The density of pigmented keratinocytes in the lesional
epidermis was scored semiquantitatively (0: absent; 1:
mild/focal; 2: moderate; 3: dense/diffuse).

Figure 1. A schematic presentation of nuclear minor diameter
(R) of a melanocyte.
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Figure 2. Melanocyte density was lower in the SK (×400) (a), compared to the BCC (×400) (b) (blue
arrows indicate some SOX-10 positive melanocytes).

Figure 3. Measuring the short axis of the three largest melanocytes. The nuclear minor diameters in
the melanocytes of the SK sections (×400) (a) were lower than those in the BCC specimens (×400) (b).

Figure 4. The tendency of the SOX10-positive melanocytes to show diffuse/epidermal basal distribution.
Melanocytes in SK were not diffuse in the tumour lobules but mostly spread along the basal layer of the
tumour (x400) (a), in the pigmented areas of the BCC, melanocytes were interspersed not only along
the basal layer of the tumour but also among the tumour cells in the central part of the tumour nest
(×100) (b).

2.4. Statistical analysis
Numerical data were summarized with mean±standard
deviation or median (min-max) as appropriate, and
categorical data were summarized with frequencies and
percentages. The normality assumption of the data was
evaluated with the Shapiro-Wilk test. Independent samples
t-test or Mann–Whitney U test were used to compare the
data between the two groups depending on data distribution
in each measurement. One-way analysis of variance
(ANOVA) was also used to compare data for multiple

groups (tumor site: head & neck, trunk, extremities).
Pearson’s χ2 test or Fisher-Freeman-Halton test was used
to analyze categorical data according to the expected count
rule. Statistical analyses were done using SPSSv.22 package
(SPSS IBM Statistics, Armonk, New York, USA), and the
level of significance was considered as 0.05.
2.5. Ethics approval
All the procedures followed the Helsinki Declaration and
the study was approved by the local Institutional Review
Board (Decision number: 2020-09/62).
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Figure 5. The melanophages were found in the connective tissue surrounding the tumour masses
(arrows). Melanophages detected in the dermis and cystic spaces using CD68 staining were found to
occur less frequently in the SK (×200) (a) than in the BCC (×100) (b).

3. Results
In total, 49 patients with SK (32 males, 17 females) and 30
patients with BCC (19 males, 11 females) were included
in the study. The mean age of the patients was 57.2 years
(range: 17–80 years) in the SK group and 67.4 years (range:
42–87 years) in the BCC group (p = 0.01) (Table).
The most common location of the BCC was the head–
neck region (n = 26; 86.6%), followed by the trunk (n = 2;
6.7%) and extremities (n = 2; 6.7%). The most common
histological subtype of BCC was the solid type (n = 9; 30%),
followed by the micronoduler (n = 8; 26.7%), nodulocystic
(n = 6; 19.9%), adenoid (n = 3; 10%), superficial (n = 2;
6.7%), and infiltrative (n = 2; 6.7%) types.
The most common location of the SK was the head–
neck region (n = 24; 49%), followed by the trunk (n = 18;
36.7%) and extremities (n = 7; 14.3%). The most common
histological subtype was the acanthotic type (n = 29;
59.2%), followed by the hyperkeratotic (n = 9; 18.4%),
reticulated (n = 6; 12.2%), and irritated (n = 5; 10.2%)
types.
In the SK group, the average number of melanocytes
per 100 basal-layer cells was 15.3 and 9.5 for the lesional
and nonlesional areas, respectively. Therefore, we
found that the melanocyte density in the SK specimens
was approximately 1.5 times higher than that in the
peritumoural normal controls. There were no statistically
significant differences between the males and females in
terms of the average number of melanocytes per 100 basal
layer cells both in intralesional and extralesional epidermis
in SK (p = 0.474, p = 0.231). These measurements could
not be made for the BCC group, as the melanocytes are
widely distributed in this type of skin cancer as opposed to
that observed in SK.
Morphometrically, melanocyte density was lower in
the SK group (Figure 2a) compared to BCC group (Figure
2b). This finding was statistically significant (p < 0.001).
Moreover, the nuclear minor diameters in the melanocytes
of the SK sections (Figure 3a) were significantly lower
than those in the BCC specimens (p < 0.001) (Figure 3b)
(Table).
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The mean diameters of peritumoural melanocytes were
not significantly different between the BCC and SK groups
(p = 0.821) (Table). Although the melanocytes appeared
oval–round in shape in both types of tumours, they were
relatively more uniform in size and shape in the SKs. The
epidermal melanocytes were mainly limited to the basal
layer in the majority of the SK sections (Figure 4a) (59.2%),
whereas they were distributed diffusely in almost all BCC
specimens (96.7%) (Figure 4b).
The number of epidermal pigmented keratinocytes with
a score of 3 was significantly higher in the SK group (n =
31; 63.2%) than in the BCC group (n = 6; 20%) (p = 0.001),
and they were the main cells representing the pigmented
appearance of the tumours (Table). Melanophages detected
in the dermis and cystic spaces using CD68, Masson–
Fontana, and Prussian blue staining were found to occur
more frequently in the BCC specimens (90%) than in the
SK sections (71.4%) (Figure 5a,5b). However, no significant
difference was found between both tumour groups in terms
of their melanophage density scores (p = 0.206) (Table).
The melanophages were found in the connective tissue
surrounding the tumour masses.
Solar elastosis occurred more frequently in the BCC
group (n = 23; 76.6%) than in the SK group (n = 16; 32.6%)
(p = 0.000), and its presence was significantly associated
with increasing age (p = 0.010) and elevated melanocyte
density (p = 0.002). We found the mean nuclear minor
diameter for each case and compared it to solar elastosis.
There was a slight increase in melanocyte diameter based
on solar elastosis (5.85 µm vs. 5.57 µm). However, there was
no statistically significant difference for the parameter of
melanocyte diameter according to the presence or absence of
solar elastosis (p > 0.05) among the whole study population.
Although there was a slight increase in melanocyte diameter
in the presence of solar elastosis, no statistical significance
was found in both the BCC (mean melanocyte diameter: 6.21
µm vs. 6.14 µm; p > 0.05) and SK groups (mean melanocyte
diameter: 5.45 µm vs. 5.27 µm; p > 0.05).
In total, 13 BCC specimens (43.3%) and 1 SK section
(2%) showed ulceration (p < 0.0001) (Table). There
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Table. Clinicopathological characteristics of the study population.
SK (n = 49)

BCC (n = 30)

p value

Male

32

19

0.859

Female

17

11

57.3

67.4

0.01

Head/neck

24

26

0.003

Trunk

18

2

Extremities

7

2

Yes

16

23

No

33

7

Diffuse

20

29

Peripheral

29

1

Melanocyte density in the epithelium (per 500 μm; ×400)

23.5

63.5

<0.001

Normal melanocytic nuclear diameter (μm)

5.3

5.2

0.821

Intralesional melanocytic diameter (μm)

5.34

6.19

<0.001

1

5

9

0.001

2

13

15

3

31

6

0

14

3

1

18

11

2

9

9

3

8

7

Yes

1

13

No

48

17

Gender

Age (17–87 years)
Tumor site

Solar elastosis
<0.001

Melanocytic distribution
<0.001

Epidermal pigmented keratinocyte density

Dermal melanophages
0.206

Epidermal ulceration

were no significant differences between ulcerated and
nonulcerated cases for the parameters of melanocyte
diameter, melanocyte density, pigmented keratinocyte
density, and dermal melanophages. Moreover, the presence
of ulcers in patients with BCC did not differ significantly
according to sex (p = 0.132).
4. Discussion
Nowadays, in addition to traditional histopathology for
the diagnosis and surgical treatment of skin cancers, the
quantitative assessment of melanocytic parameters using
image analysis is becoming increasingly important as well.
To investigate whether there are significant differences in
the morphometry of melanocytes between pigmented BCC

<0.001

and SK, SOX10 staining of archived formalin-fixed paraffinembedded tissue sections was carried out in this study. The
nuclear staining quality of SOX10 facilitates localisation of
the melanocytes within the epidermis and measurement of
the nuclear parameters by image analysis [5,6].
Melanin is usually formed in nodular, micronodular,
multifocal superficial, or follicular variants of BCC [8].
However, in our study, the most common tumour subtypes
found to contain pigmentation were nodular, micronodular,
and nodulocystic, and these were considered to fall into
the category of pigmented BCC based on WHO 2018
classification.
The melanocytes in SK were mostly basally located, and
their nuclear sizes were significantly smaller than those
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of the melanocytes in BCC, with a ratio of approximately
1.16:1. The melanocytes in SK appeared to be associated
with the inactive state of the cell as opposed to the
hyperactive, large melanocytes in BCC.
The origin of melanocytes in pigmented BCC is
unclear, albeit different hypotheses have been proposed.
For example, the melanocytes may have migrated from
the neighbouring epidermis. Given that several previous
studies have reported the presence of melanocyteattracting chemotactic factors in some tumours,
including BCC, the possibility of nonneoplastic epidermal
melanocytes migrating to and colonising tumour areas
after BCC formation is quite feasible [9–11].
It is widely accepted that there is a close relationship
between the derivation of BCC and the histogenesis of hair
follicles. Melanocytes may also originate from BCC cells
in hair follicles. These findings have provided evidence
of a correlation between melanocytes in pigmented BCC
and those in the hair follicle. In other words, melanocytes
in pigmented BCC may be derived from hair follicles
accompanied by BCC cell differentiation [9–11]. Taken
together, these reports and the current findings provide
a possible explanation (at least in part) for the observed
racial trends in pigmented BCC prevalence; that is,
clinically pigmented BCC occurs more commonly in
races with naturally black hair than in those with naturally
blonde hair [12]. Considering that SK also results from
basaloid keratinocytes that had matured from basal cells,
it may explain the increase in melanised keratinocytes and
melanocytes in this type of skin tumour as well.
In the normal human epidermis, melanocytes are
in close contact with a large number of keratinocytes,
supplying them with melanin [13,14]. Keratinocytes are
active secretory cells that stimulate melanocyte growth in
a regulated manner in vitro [15]. Benign melanocytes in
BCC were observed to have diverged when in the normal
human epidermis, suggesting that neoplastic keratinocytes
may still regulate the growth of the melanocytes that
harbour them [16]. This study also found that the number
of malignant melanocytes in pure melanoma in situ (MIS)
were lower than malignant melanocytes in a BCC tumour
in collision with melanoma in situ (BCC+MIS) [16]. It is
also possible that a BCC is easily populated by melanomas
because the cells are met with little resistance by the poorly
adherent BCC cells [16]. Although the keratinocytemelanocyte interaction unit may still work in benign
epithelial tumours such as SK, it can be assumed that the
unit is disrupted as it shifts to the malignant epithelial
tumour or collision tumour spectrum, suggesting that
different mechanisms or regulators that stimulate the
proliferation of melanocytes cannot effectively limit their
proliferation as well.
Florell et al. hypothesised that the BCC entraps
melanocytes as the tumour grows, given that melanocytes
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are located in the epidermal basal layer from which
BCCs arise [16]. They argued that a similar phenomenon
was observed in studies of pigmented epidermotropic
breast cancer metastasis in which melanocytes were
colonised [17–20]. However, in our study, melanocytes
were seen throughout the basal layer in the majority of
SKs. Considering that SKs also originate from basal cells,
our results do not support the view of Florell et al. [16].
At this point, we can only speculate on whether these
melanocytes originated from the basal cells. It is possible
that pluripotent stem cells differentiated into melanocytes.
In this context, electron microscopy studies are needed to
evaluate the ultrastructures of the melanocytes in basal
cells and in ordinary melanocytic lesions.
It has been reported that the pigmented areas of SK
and BCC are rich in dendritic melanocytes, which have
been suggested to provide melanosome transfer between
two tumour cells [16,18,20–22]. However, it is notable in
our study that the melanocytes in the pigmented parts
of both tumours were oval-round in shape rather than
dendritic, which again raises the question of whether the
melanocytes had originated from basal cells rather than
the neural crest.
Our morphometric and immunohistochemical
findings showed that in the pigmented areas of the BCC,
melanocytes were interspersed not only along with the
basal layer of the tumour but also among the tumour
cells in the central part of the tumour nest, which is
consistent with the findings of Lao et al. [12]. However,
using the dihydroxyphenylalanine (DOPA) reaction,
Deppe et al. demonstrated that melanocytes were localised
predominantly in the periphery of the BCC [23]. However,
contrary to the results reported in the literature, we found
that the melanocytes in SK were not diffuse in the tumour
lobules but mostly spread along with the basal layer of the
tumour [24]. Moreover, they were distributed in a ratio of
approximately 15 to every 100 basal cells along the basal
lamina. The melanocyte density in the SK specimens
was approximately 1.5 times higher than that in the
peritumoural normal controls.
It has been reported that pigmented BCCs contain
more melanocytes than their nonpigmented counterparts
and that the clinically pigmented appearance is provided
by the melanocytes rather than the melanin pigments
[25]. According to our present findings, we can state that
the melanocytes and melanophages contributed more to
the clinically pigmented appearance in BCCs than they
did in SKs. However, the source of the darkly pigmented
appearance of both tumours was melanin-containing
keratinocytes, being more predominantly so for the SK
specimens.
It has been suggested that ulceration in pigmentcontaining BCCs causes melanin pigments to be released
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and subsequently phagocytosed by the surrounding
tumour cells [22]. However, in our study, no significant
relationship could be established between the presence
of ulceration and the proliferation of melanocytes or the
density of epidermal pigmented keratinocytes.
Another finding in our study was that chronic sun
damage increased the density of melanocytes in the
lesions. Although there was no statistically significant
difference in the diameters of melanocytes between both
tumour groups, we believe that chronic sun damage may
affect both the density and diameter. The evaluation of a
larger case series is needed to reach a definitive conclusion
on this aspect.
5. Conclusion
In this study, differences in the morphology and
morphometry of melanocytes were found between those
in BCC and those in SK tissue specimens. However, as
discussed above, because of the possibility of pluripotent
stem cells differentiating into melanocytes, the
determination of the melanocyte source in pigmented

epithelial tumours on the basis of a morphometric
analysis alone is controversial. In this context, an electron
microscopy study is needed to evaluate the ultrastructural
features of the melanocytes in ordinary melanocytic
lesions and in basal cells. The limitation of our study is
the absence of such ultrastructural findings and a partially
small case population. Notwithstanding, this study is
the first step towards an objective quantification of the
melanocytes in pigmented epithelial tumours and may
provide a morphological background for future studies on
these skin lesions.
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